AB-Biotics in the Media
10
May
PMFARMA
AB-Biotics launches a new version of Neurofarmagen with 39 active principles analyzed
The analysis predicts patient response to drugs commonly used in depression, schizophrenia, epilepsy and bipolar disorder
30
Apr
Expansión
Biotech companies ask the government to buy Catalan technology
AB-BIOTICS, INTELLIGENT PHARMA and STARLAB introduce their projects
22
Apr
El Economista
AB-Biotics will double its capital after summer and will begin a purchasing phase
The company analyzes purchases and alliances with laboratories in seven countries
